|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-04
|
$701,778
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Building Research Capacity to Address the Challenge of Non Communicable Diseases and Injuries in Rwanda The GUKORANA Research Center
|
1P20CA210284-01A1
|
$340,631
|
|
CASTLE, PHILIP
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
MOTILITY AND INVASION
|
5P01CA100324-15
|
$2,028,990
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Training of Surgeons for Studies of the Tumor Microenvironment
|
5T32CA200561-03
|
$277,522
|
|
MICHLER, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Mechanisms of Formation and Progression of Preleukemic Stem Cells
|
1R01CA217092-01
|
$397,371
|
|
STEIDL, ULRICH
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Contributions of sympathetic signals to prostate cancer progression.
|
5F30CA203446-02
|
$49,044
|
|
ZAHALKA, ALI
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Methods in Clinical Cancer Research Workshop
|
5R25CA068647-20
|
$224,999
|
|
VON HOFF, DANIEL
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Colon cancer risk-stratification via optical analysis of rectal ultrastructure
|
5R44CA199667-02
|
$835,665
|
|
WALI, RAMESH
|
AMERICAN BIOOPTICS, LLC
|
|
2017 Annual Meeting of the American Society for Investigative Pathology
|
1R13CA217139-01
|
$7,000
|
|
MITCHELL, RICHARD
|
AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY
|
|
Development of a Pharmacoprotector for Platinum Toxicities
|
1R43CA206705-01A1
|
$225,000
|
|
CHIEN, HUAN-CHIEH
|
APRICITY THERAPEUTICS, INC.
|
|
Cancer-associated fibroblast in the regulation of bladder cancer stem cells
|
5R01CA175397-05
|
$324,738
|
|
CHAN, KEITH SYSON
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
1R21CA217137-01
|
$209,093
|
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer
|
5R01CA072038-19
|
$320,963
|
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Germ Cell Gene TDRD1 As A Novel Prostate Cancer Biomarker
|
1R01CA211861-01A1
|
$362,569
|
|
HE, BIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cognitive Change after Proton RT vs. Photon or Surgery for Pediatric Brain Tumor
|
5R01CA187202-04
|
$577,030
|
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Lung Cancer Prediction Models Incorporating Exome Data from Extreme Phenotypes
|
5K07CA181480-04
|
$127,883
|
|
LIU, YANHONG
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-04
|
$2,300,000
|
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Evaluating utility and improving implementation of genomic sequencing for pediatr
|
U01HG006485-05
|
$900,000
|
|
Plon, Sharon
|
BAYLOR COLLEGE OF MEDICINE
|
|
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
|
5R01CA181808-04
|
$336,565
|
|
RICHARDS, JOANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Delineating racially distinct metabolic pathways in triple negative breast cancer
|
5U01CA179674-04
|
$334,143
|
|
SREEKUMAR, ARUN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Osteoclast-independent mechanisms of early-stage bone colonization of breast canc
|
5R01CA183878-04
|
$324,738
|
|
ZHANG, XIANG
|
BAYLOR COLLEGE OF MEDICINE
|
|
Integration of Palliative Care for Cancer Patients on Phase I Trials
|
5R01CA177562-04
|
$1,356,827
|
|
FERRELL, BETTY
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Geriatric Oncology: Educating nurses to improve quality care
|
5R25CA183723-03
|
$272,197
|
|
HURRIA, ARTI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
City of Hope Clinical Oncology Career Research Development Program
|
5K12CA001727-23
|
$735,835
|
|
MORTIMER, JOANNE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas
|
5R01CA184585-04
|
$802,610
|
|
NEUHAUSEN, SUSAN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-04
|
$108,798
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas
|
5R01CA198076-03
|
$1
|
|
PORTNOW, JANA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
5U01CA199252-03
|
$1,041,188
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-13
|
$2,300,000
|
|
MCDERMOTT, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting Tumor Suppressive Pathways for Cancer Therapy
|
5R35CA197529-03
|
$1,044,000
|
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of regulation by RNA in acute myeloid leukemia
|
5R35CA197697-03
|
$885,280
|
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
RASL-Seq Expression Profiling of FFPE Tissues
|
5R33CA183688-03
|
$332,225
|
|
YEAKLEY, JOANNE
|
BIOSPYDER TECHNOLOGIES, INC.
|
|
Uncoupling obesity from breast cancer in African American women
|
5U01CA182898-05
|
$650,118
|
|
DENIS, GERALD
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
MicroRNA128 Regulation of Polycomb Repressor Complexes1 and 2 in Glioblastoma
|
5R01CA176203-04
|
$343,900
|
|
GODLEWSKI, JAKUB
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
5U24CA180918-05
|
$668,865
|
|
KIKINIS, RON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
(PQ4) Elucidating Determinants of Susceptibility to Tumorigenesis in the Skin
|
5R21CA208298-02
|
$180,459
|
|
RAMSEY, MATTHEW
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Investigating the HSF1 Cancer Network
|
5R01CA194005-02
|
$406,031
|
|
SANTAGATA, SANDRO
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-18
|
$2,424,605
|
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health Study
|
5UM1CA186107-04
|
$2,864,572
|
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
PQB-3: Discovery and validation of the driving mediators of cancer cachexia
|
5R01CA190101-04
|
$585,575
|
|
GOLUB, TODD
|
BROAD INSTITUTE, INC.
|
|
Systematic identification of oncogenic KRAS synthetic lethal interactions
|
5U01CA199253-03
|
$807,776
|
|
HAHN, WILLIAM
|
BROAD INSTITUTE, INC.
|
|
When Outcomes Matter: A Temporal Analysis of Instrumental and Affective Outcomes of Exercise Behavior using Ecological Momentary Assessment
|
5F31CA206245-02
|
$44,044
|
|
EMERSON, JESSICA
|
BROWN UNIVERSITY
|
|
A Pap Test Intervention to Enhance Decision Making among Pacific Islander Women
|
5R01CA149324-02
|
$498,557
|
$498,557
|
TANJASIRI, SORA
|
CALIFORNIA STATE UNIVERSITY FULLERTON
|
|
Epigenetically Reversing Paclitaxel Resistance in Triple Negative Breast Cancers
|
1F32CA210426-01A1
|
$61,866
|
|
GAYLE, SYLVIA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Clinical Oncology Research Career Development Program (CORP)
|
5K12CA076917-20
|
$733,989
|
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Repurposing Anti-cancer Drugs to Prevent Growth of Osteosarcoma Metastases
|
5R21CA209304-02
|
$206,843
|
|
GREENFIELD, EDWARD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
MR Fingerprinting and Computerized Decision Support for Prostate Cancer
|
1R01CA208236-01A1
|
$554,035
|
|
GULANI, VIKAS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Treatment of glioblastoma using chain-like nanoparticles
|
5U01CA198892-03
|
$617,516
|
|
KARATHANASIS, EFSTATHIOS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Imaging Liver Cancer Proliferation
|
5R01CA204373-02
|
$395,646
|
|
LEE, ZHENGHONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeted MRI contrast agents for differential diagnosis of prostate cancer
|
1R01CA211762-01A1
|
$423,352
|
|
LU, ZHENG-RONG
|
CASE WESTERN RESERVE UNIVERSITY
|
Total relevant funding to Cervical Cancer Education for this search: $8,223,074
|